Welcome to LookChem.com Sign In|Join Free
  • or
(S)-{9-[(3,4-dichlorophenyl)thio]-1-isopropyl-7,8-dihydro-6H-pyrido[3,4-b]pyrrolizin-8-yl}acetic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

794535-46-9

Post Buying Request

794535-46-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

794535-46-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 794535-46-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,4,5,3 and 5 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 794535-46:
(8*7)+(7*9)+(6*4)+(5*5)+(4*3)+(3*5)+(2*4)+(1*6)=209
209 % 10 = 9
So 794535-46-9 is a valid CAS Registry Number.

794535-46-9Upstream product

794535-46-9Downstream Products

794535-46-9Relevant academic research and scientific papers

Discovery of potent and selective DP1 receptor antagonists in the azaindole series

Leblanc, Yves,Roy, Patrick,Dufresne, Claude,Lachance, Nicolas,Wang, Zhaoyin,O'Neill, Gary,Greig, Gillian,Denis, Danielle,Mathieu, Marie-Claude,Slipetz, Deborah,Sawyer, Nicole,Tsou, Nancy

, p. 2125 - 2128 (2009)

Azaindole based structures were evaluated as DP1 receptor antagonists. This work has lead to the discovery of potent, selective and distinct DP1 receptor antagonists.

NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

-

Page/Page column 83-84, (2010/11/08)

The present invention encompasses compounds of Formula (I); as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating dyslipidemias. Pharmaceutical compositions and methods of use are also included.

NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

-

Page/Page column 67, (2008/06/13)

The present invention encompasses compounds of Formula I: as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating dyslipidemias. Pharmaceutical compositions and methods of use are also included.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 794535-46-9